Page last updated: 2024-09-04

3,4-dihydro-5-methyl-1(2h)-isoquinolinone and 2,4(1h,3h)-quinazolinedione

3,4-dihydro-5-methyl-1(2h)-isoquinolinone has been researched along with 2,4(1h,3h)-quinazolinedione in 1 studies

Compound Research Comparison

Studies
(3,4-dihydro-5-methyl-1(2h)-isoquinolinone)
Trials
(3,4-dihydro-5-methyl-1(2h)-isoquinolinone)
Recent Studies (post-2010)
(3,4-dihydro-5-methyl-1(2h)-isoquinolinone)
Studies
(2,4(1h,3h)-quinazolinedione)
Trials
(2,4(1h,3h)-quinazolinedione)
Recent Studies (post-2010) (2,4(1h,3h)-quinazolinedione)
16022507

Protein Interaction Comparison

ProteinTaxonomy3,4-dihydro-5-methyl-1(2h)-isoquinolinone (IC50)2,4(1h,3h)-quinazolinedione (IC50)
Poly [ADP-ribose] polymerase 1Homo sapiens (human)8.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Camaioni, E; Costantino, G; Macchiarulo, A; Pellicciari, R1

Other Studies

1 other study(ies) available for 3,4-dihydro-5-methyl-1(2h)-isoquinolinone and 2,4(1h,3h)-quinazolinedione

ArticleYear
Modeling of poly(ADP-ribose)polymerase (PARP) inhibitors. Docking of ligands and quantitative structure-activity relationship analysis.
    Journal of medicinal chemistry, 2001, Nov-08, Volume: 44, Issue:23

    Topics: Catalytic Domain; Crystallography, X-Ray; Enzyme Inhibitors; Ligands; Models, Molecular; Naphthalenes; Phenanthridines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Binding; Quantitative Structure-Activity Relationship; Quinazolines

2001